Our Press Releases | Association for Accessible Medicines

Jun 26, 2019 | Jewel Smith

AAM Announces New 2019 Members

May 23, 2019 | Rachel Schwartz

AAM Statement on FTC Report on Patent Settlements

May 21, 2019 | Rachel Schwartz

AAM Statement on House Bills 965, 1499 and 938

May 17, 2019 | Rachel Schwartz

AAM Statement on the Importance of Generic and Biosimilar Quality and Robust Competition

May 16, 2019 | Rachel Schwartz

How Generic Drug Makers Are Responding to Price-Fixing Lawsuit

May 13, 2019 | Rachel Schwartz

The 11th Annual Edition of AAM Access & Savings Report Finds Generic Savings Totaled $293 Billion in 2018

May 12, 2019 | Rachel Schwartz

Response to 60 Minutes May 12, 2019: AAM Statement on the Importance of Competition to Promote Accessibility and Affordability of Medicines

May 8, 2019 | Rachel Schwartz

AAM Statement on Introduction of the Affordable Prescriptions for Patients Act

May 7, 2019 | Jeff Francer

AAM Statement: Senate Judiciary Committee Hearing on Patents and Drug Prices

Apr 24, 2019 | Jewel Smith

AAM Announces 2019 Associate Members

AAM Statement on House Energy & Commerce Passage of the CREATES Act

Apr 3, 2019 | Rachel Schwartz

AAM Statement on House Energy & Commerce Passage of the CREATES Act

Responding to the CY 2020 MA Capitation Rates and Medicare Advantage and Part D Payment Policies and Final Call Letter

Apr 1, 2019 | Rachel Schwartz

AAM Response to CMS Final 2020 Call Letter